Company research / CYTOF

Altamira Therapeutics Ltd. (CYTOF)

Build a valuation ↗↓ Download CSV

CIK 0001601936

Key ratios (year ended 2020-12-31)

-48.9%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 6-K · 2025-08-29

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2020-12-31	2019-12-31	2018-12-31
Net Income	-8.20M CHF	-6.63M CHF	-11.50M CHF
Total Liabilities	840.7K CHF	4.4K CHF	2.11M CHF
Shareholders' Equity	16.77M CHF	6.04M CHF	—